Which of the following drugs is used to reverse the effect of d-tubocurarineh –
**Core Concept**
The question is testing the student's knowledge of the reversal of non-depolarizing neuromuscular blockers, specifically d-tubocurarine, which is a long-acting competitive antagonist of the nicotinic acetylcholine receptor. The underlying principle involves the use of a drug that can competitively inhibit the action of the neuromuscular blocker, thereby restoring neuromuscular transmission.
**Why the Correct Answer is Right**
The correct answer is **Neostigmine**. Neostigmine is a cholinesterase inhibitor that works by preventing the breakdown of acetylcholine, thereby increasing the concentration of acetylcholine available for neuromuscular transmission. This effect is particularly useful in reversing the blockade caused by non-depolarizing neuromuscular blockers like d-tubocurarine. Neostigmine acts by competitively inhibiting acetylcholinesterase, the enzyme responsible for the breakdown of acetylcholine, thereby increasing the concentration of acetylcholine in the synaptic cleft.
**Why Each Wrong Option is Incorrect**
**Option A:** Atropine is an anticholinergic agent that would actually worsen the neuromuscular blockade by blocking the muscarinic receptors, thereby reducing acetylcholine release.
**Option B:** Succinylcholine is a depolarizing neuromuscular blocker, which would not reverse the effect of d-tubocurarine but would instead cause a depolarizing blockade.
**Option C:** Prazosin is an alpha-1 adrenergic receptor antagonist, which is not related to the reversal of neuromuscular blockade caused by d-tubocurarine.
**Clinical Pearl / High-Yield Fact**
When using neostigmine to reverse neuromuscular blockade, it's essential to administer it in the presence of a peripheral nerve stimulator to monitor the return of neuromuscular function and to avoid over-sedation or respiratory depression.
**Correct Answer:** C. Neostigmine.